Literature DB >> 22117134

Who are the children at risk? Lessons learned from measles outbreaks.

C Stein-Zamir1, H Shoob, N Abramson, G Zentner.   

Abstract

We investigated a measles outbreak in the Jerusalem district in 2007-2008 (992 cases). Most cases (72·6%) were aged <15 years, 42·9% aged <5 years, and 12·8% were infants aged <1 year. The peak incidence rate was in infants aged 6-12 months (916·2/100 000). This represents a significant shift from former outbreaks in 2003-2004, where the peak incidence was in the 1-4 years age group. Of children aged <5 years the proportion aged 6-12 months tripled (7·7% vs. 25·6%). In a case-control study (74 cases, 148 controls) children who developed measles were less likely to be registered in a well-baby clinic and had lower overall immunization coverage. The differences in proportions for registration, DTaP3 and MMR1 coverage were 35·1%, 48·6% and 80·8%, respectively (all P<0·001). Rising birth order of cases and their siblings was associated with non-registration and non-compliance with MMR immunization. The vulnerability of young infants and the risk markers noted above should be taken into account in planning intervention programmes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22117134     DOI: 10.1017/S095026881100238X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

1.  Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.

Authors:  C Stein Zamir; H Schroeder; H Shoob; N Abramson; G Zentner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Knowledge, Attitudes and Perceptions About Routine Childhood Vaccinations Among Jewish Ultra-Orthodox Mothers Residing in Communities with Low Vaccination Coverage in the Jerusalem District.

Authors:  Chen Stein Zamir; Avi Israeli
Journal:  Matern Child Health J       Date:  2017-05

3.  Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.

Authors:  Hagai Levine; Salman Zarka; Omer E Ankol; Vladi Rozhavski; Nadav Davidovitch; Yair Aboudy; Ran D Balicer
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.

Authors:  Chen Stein-Zamir; Avi Israeli
Journal:  Hum Vaccin Immunother       Date:  2017-07-11       Impact factor: 3.452

Review 5.  Antivirals targeting paramyxovirus membrane fusion.

Authors:  Erik M Contreras; Isaac Abrrey Monreal; Martin Ruvalcaba; Victoria Ortega; Hector C Aguilar
Journal:  Curr Opin Virol       Date:  2021-09-27       Impact factor: 7.090

6.  Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.

Authors:  Ravit Bassal; Victoria Indenbaum; Rakefet Pando; Tal Levin; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Ella Mendelson; Dani Cohen; Tamy Shohat
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

7.  Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Authors:  Jeremy C Welsch; Aparna Talekar; Cyrille Mathieu; Antonello Pessi; Anne Moscona; Branka Horvat; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

8.  Preventive health services for young children in Israel: historical development and current challenges.

Authors:  Deena R Zimmerman; Gina Verbov; Naomi Edelstein; Chen Stein-Zamir
Journal:  Isr J Health Policy Res       Date:  2019-02-07

9.  The epidemiological and clinical characteristics of measles in Wenzhou, China, 2000-2010.

Authors:  Z W Xu; Y P Chen; M J Yang; W C Li; Q Liu; J Lin
Journal:  Epidemiol Infect       Date:  2013-03-18       Impact factor: 4.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.